We identified potential mechanisms for further study that may lead to a more comprehensive understanding of how differential SPI1 expression may alter crucial microglial functions, including regulation of the immune response, complement system, and phagocytic clearance in AD pathology. This evidence concerns the gene SPI1 and Alzheimer disease.